Kyle Piskel
Chief Financial Officer · Adaptive Biotechnologies Corp
- 2024
- May 20, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kyle Piskel files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Chad M. Robins - $37.85M in ADPT purchases and sales in the last 12 months
- Harlan S. Robins - $29.48M in ADPT purchases and sales in the last 12 months
- Julie Rubinstein - $16.25M in ADPT purchases and sales in the last 12 months
- Sharon Benzeno - $14.48M in ADPT purchases and sales in the last 12 months
- Francis Lo - $11.99M in ADPT purchases and sales in the last 12 months
- Peter M. Neupert - $3.14M in ADPT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kyle Piskel?
Kyle Piskel is a corporate insider, tracked as Chief Financial Officer of Adaptive Biotechnologies Corp (ADPT). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kyle Piskel last file a Form 4?
The most recent primary Form 4 on record is dated 20 May 2026, one of 8 filings going back to 2024.
Has Kyle Piskel been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($3.58M) across all tracked filings.
